R57K Polymorphism in the Human Immunodeficiency Virus Type 1 Protease as Predictor of Early Virological Failure in a Cohort of Antiretroviral-Naive Patients Treated Mostly with a Nelfinavir-Containing Regimen

In 243 antiretroviral-naive human immunodeficiency-infected patients starting a first-line-protease inhibitor (mainly nelfinavir)-containing therapy, the presence of the polymorphism R57K in the protease at the inception of therapy was independently associated with a higher rate of virological failu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Masquelier, Bernard, Droz, Cecile, Dary, Martin, Perronne, Christian, Ferré, Virginie, Spire, Bruno, Descamps, Diane, Raffi, François, Brun-Vézinet, Françoise, Chêne, Geneviève
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2003
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC253793/
https://ncbi.nlm.nih.gov/pubmed/14576131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.11.3623-3626.2003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller